Clinical Trial Update: ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation

View source ↗

Summary

Clinical trial ABSORB A Cohort A for the everolimus-eluting coronary stent system by Abbott Medical Devices has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Coronary Disease, Coronary Artery Disease | Status: COMPLETED